04/27/2023 Bormioli Pharma SpA (BORMPH) EUR350m (including EUR22.980m of Exchange Notes) 144A/Reg S sr sec FRN due 05/15/28 (5y). NC1 (MWC B+50bp), then at 100. B3/B-/B (stable/stable/stable). Via BNP/GS (B&D) jt glocos and jt physical books/CA/IMI jt books. No reg rights. List Lux. NY law. Floats/pays quarterly. Settles 05/10 (T+7). Reg S ISIN: XS2616351867. IPT: E+525-550bp (zero floor) 95 OID. Px talk: 3mE+550bp (zero floor) 95.50 area (+/- 0.25 pts). Priced: 3mE+550bp (zero floor) at 95.50.
Roadshow 04/24-27 (investor call at 10:30am 04/24). Books closed at 1pm UKT 04/27. UOP: repay EUR18m drawn on its revolver, repay EUR26m bilateral facilities and EUR280m FRN due 11/15/24 (callable at 100). EUR22.98m of notes were placed directly in a private exchange offer with existing FRN note holders at an exchange ratio fo EUR1,047.12 exchange notes for each EUR1,000.00 of existing notes. Equity sponsor: Triton Investment Management. Biz: manufactures plastic and glass packaging for the pharmaceutical industry. HQ: Parma, Italy.